Our findings report for the first time that miR-93 promotes LACC cell EMT, migration, and invasion via targeting downregulation of BRMS1L through regulation of Wnt signaling pathway, which differs from its anti-oncogene role in ovarian cancer. The gene discussed is BRMS1L; the disease is ovarian carcinoma.